The UK's Defence and Science Technology Laboratory (DSTL) has developed a new diagnostic test for the Ebola virus which is said to offer significant advantages over the current testing method. [ + ]

The Australian Academy of Science has responded to the TGA's review into the regulation of autologous stem cell therapies, calling for the closure of a loophole which apparently allows practitioners to offer experimental and potentially risky therapies to vulnerable patients. [ + ]

Research and consulting firm GlobalData has released a report comparing the competitive positions of 35 mid-cap biotechnology companies, finding an increase in combined total revenues from $24.8 billion in 2013 to $26.5 billion in 2014. [ + ]

The UK's Defence and Science Technology Laboratory (DSTL) has developed a new diagnostic test for the Ebola virus which is said to offer significant advantages over the current testing method. [ + ]

Researchers have revealed the presence of two antibodies in a subgroup of children experiencing their first episode of psychosis, affirming a longstanding recognition that autoimmune disorders play a significant role in psychiatric illness.

Regeneus (ASX:RGS) has completed the manufacture of its off-the-shelf allogeneic stem cell therapy product, Progenza, for a human trial for the treatment of osteoarthritis (OA). This marks the first time Progenza has been produced at scale for use in a human trial.

An international research team, led by the University of Melbourne, has sequenced the genetic code of the roundworm Toxocara canis.

Tel Aviv University researchers have developed the ability to turn smartphones into powerful hyperspectral sensors, capable of identifying the chemical components of objects from a distance. [ + ]

Scientists at the University of Central Florida have developed a prostate cancer test that is said to be faster, cheaper, more sensitive and more accurate than the standard PSA test for early-stage prostate cancer. [ + ]

Monash University has opened its Green Chemical Futures building - a multidisciplinary innovation hub dedicated to supporting Australia's academic and industrial research within the chemicals manufacturing sector. [ + ]

In spite of large-scale deforestation in the tropics, vegetation has increased by almost the equivalent of 4 billion tonnes of carbon since 2003.

A study led by Sydney's Garvan Institute of Medical Research has revealed a new discovery regarding triple-negative breast cancers (TNBCs) - cancers which lack any of the three receptors (oestrogen, progesterone or HER2) that would make them responsive to targeted drugs.

The Professional Standards Councils (PSC) will fund a year-long study to identify the skills and qualities required to successfully put research to use via commercialisation. [ + ]

Molecular diagnostics company Genetic Signatures listed on the ASX today under the stock code 'GSS', following a successful IPO which achieved the maximum raising of $7.5 million. [ + ]

Setaram Instrumentation has announced DKSH Australia as its new exclusive representative in Australia and New Zealand. [ + ]